Actively Recruiting

Phase Not Applicable
Age: 40Years +
All Genders
NCT04407338

Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Post-operative Functional Incapacity (BDYNCLIN)

Led by Quanta Medical · Updated on 2025-03-19

216

Participants Needed

2

Research Sites

491 weeks

Total Duration

On this page

Sponsors

Q

Quanta Medical

Lead Sponsor

C

Cousin Biotech

Collaborating Sponsor

AI-Summary

What this Trial Is About

Degenerative Lumbar Spinal Stenosis (LSS) is an extremely common condition affecting more than 102 million people each year. It is a narrowing of the spinal canal in the lower back. It causes pain and even disorders of the lower limbs. When the symptoms get worse and the individual feels functional discomfort despite medical treatment, surgical intervention is recommended. Two surgical options are available: Rigid Stabilization Devices as conventional fusion with or without cage, or dynamic stabilization system as B-DYN device, this system is called "dynamic" because it allows the stabilization of the operated part while preserving a certain mobility. The main objective of this study is to evaluate the efficacy and tolerance of B-Dyn versus conventional bolted fusion (with or without cage) in the treatment of degenerative lumbar stenosis (DLS) on the degree of postoperative functional incapacity. So the investigator's hypothesis is that the use of the B-DYN device in the treatment of DLS could lead to the maintenance of functional disability related to low back pain (maintenance of walking and mobility). Another important point to be demonstrated in this study is the preservation of the mobility of the stage overlying the assembly performed by B-Dyn. Indeed, the continued degeneration of segments adjacent to lumbar vertebral fusions is a concern for surgeons For B-Dyn, which is a dynamic stabilization, the combination of rigid and flexible parts allows the mobility of the overlying stage to be preserved and could also lead to a decrease in adjacent syndrome in the long-term compared to the use of conventional fusion. The duration of patient follow-up is 60 months. The inclusion period is 56 months to recruit the necessary number of subjects for the study (a total of 216 patients is expected).

CONDITIONS

Official Title

Efficacy and Tolerance Study of B-DYN Versus Conventional Fusion in the Treatment of Lumbar Stenosis on the Degree of Post-operative Functional Incapacity (BDYNCLIN)

Who Can Participate

Age: 40Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of lumbar spinal stenosis on 1 to 3 disc levels confirmed by MRI
  • Grade 1 or no spondylolisthesis at the upper surgical level
  • Neurological symptoms or neurogenic claudication in one or both legs with pain score over 30
  • Symptoms lasting more than 3 months despite medical treatment
  • No contraindications for fusion or B-Dyn device application
  • Age 40 years or older
  • Able to give informed written consent
  • Able to communicate in the language of the study country
  • Affiliated with or entitled to a social security scheme
Not Eligible

You will not qualify if you...

  • Spondylolisthesis greater than grade 1 at the upper surgical level
  • Surgery required on more than 3 disc levels
  • Degenerative scoliosis with Cobb angle over 20 degrees
  • Stenosis only at the L5-S1 level
  • Previous instrumented lumbar surgery on upper or lower level (except intra-spinous device on lower level)
  • Stenosis not caused by degenerative changes
  • Isolated disc herniation
  • Other specific vertebral damage such as ankylosing spondylitis, cancer, or neurological disorders
  • History of vertebral compression fractures at instrumented level
  • History of osteoporotic fractures
  • Psychological disorders or drug addiction preventing study participation
  • Chronic infection
  • Withdrawal of consent
  • Pregnancy or breastfeeding
  • Participation in another clinical trial within 3 months prior to initial visit
  • Predicted unavailability during study or legal incapacity
  • Allergy to any component of the medical device

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

CHU [University Hospital Center]of Bordeaux - Le Tripode - GH Pellegrin/ Department of Orthopaedic and Trauma Surgery Spinal Surgery Unit

Bordeaux, France, 33000

Actively Recruiting

2

Clinique Des Cedres

Cornebarrieu, France, 31700

Not Yet Recruiting

Loading map...

Research Team

V

Vincent POINTILLART, Professor

CONTACT

B

Bertrand DEBONO, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here